| |
| |
|
| Insider
Information: |
Meury William |
| Relationship: |
|
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
65,000 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,318,200 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
65,000 |
|
|
| Total
Value |
$1,318,200 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 62.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Allergan plc |
AGN |
EVP & Chief Commercial... |
2020-05-08 |
0 |
2014-07-01 |
0 |
Premium* |
|
|
Syndax Pharmaceuticals Inc |
SNDX |
|
2024-02-07 |
65,000 |
2021-02-03 |
0 |
Premium* |
|
|
Karuna Therapeutics, Inc. |
KRTX |
|
2024-03-18 |
0 |
2023-01-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
40 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AGN |
Allergan plc |
EVP & Chief Commercial Officer |
• – – |
2019-04-03 |
4 |
D |
$145.71 |
$126,913 |
D/D |
(871) |
13,327 |
0 |
- |
|
| AGN |
Allergan plc |
EVP & Chief Commercial Officer |
• – – |
2019-12-31 |
4 |
D |
$191.17 |
$287,520 |
D/D |
(1,504) |
11,823 |
0 |
- |
|
| AGN |
Allergan plc |
EVP & Chief Commercial Officer |
• – – |
2020-03-02 |
4 |
A |
$193.84 |
$4,199,931 |
D/D |
21,667 |
33,490 |
0 |
- |
|
| AGN |
Allergan plc |
EVP & Chief Commercial Officer |
• – – |
2020-04-03 |
4 |
D |
$175.71 |
$150,232 |
D/D |
(855) |
32,635 |
0 |
- |
|
| AGN |
Allergan plc |
EVP & Chief Commercial Officer |
• – – |
2020-05-08 |
4 |
D |
$0.00 |
$0 |
D/D |
(7,434) |
0 |
0 |
- |
|
| AGN |
Allergan plc |
EVP & Chief Commercial Officer |
• – – |
2020-05-08 |
4 |
D |
$0.00 |
$0 |
D/D |
(25,201) |
0 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
|
– • – |
2021-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
16,000 |
16,000 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
|
– • – |
2022-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
16,000 |
32,000 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
President and CEO |
• • – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
38,073 |
38,073 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
|
– • – |
2023-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
16,000 |
48,000 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
|
– • – |
2023-08-02 |
4 |
OE |
$7.11 |
$665,250 |
D/D |
83,000 |
72,000 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
|
– • – |
2023-08-02 |
4 |
S |
$20.45 |
$1,697,810 |
D/D |
(83,000) |
48,000 |
0 |
% |
|
| KRTX |
Karuna Therapeutics, Inc. |
President and CEO |
• • – |
2023-12-28 |
4 |
D |
$316.30 |
$2,749,912 |
D/D |
(8,694) |
29,379 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
|
– • – |
2024-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
17,000 |
65,000 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
President and CEO |
• • – |
2024-03-18 |
4 |
D |
$330.00 |
$9,695,070 |
D/D |
(29,379) |
0 |
0 |
- |
|
40 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
